Cybersecurity & Risk

Can You Prove What the AI Did?

Veeva's agent builds your study in a day. FDA now accepts computer models as evidence. The audit trail is your problem.

Can You Show Your Work?

AI is moving into regulated R&D and the plant floor faster than the proof that it is controlled.

Your Mandate Just Grew. Your Budget Didn't.

The mandate keeps widening while the resources keep shrinking, and this week's news is the proof.

"The SSO Platform Is the Control Plane": Inside This Week's Identity Breaches

McKesson, Elekta, and a Health-ISAC alert all point at the same weak link: single sign-on.

Your Tech Stack Is Now Your Operating Model

A cyberattack stopped a device maker from shipping, and every headline pointed back to the same question.

Your AI Governance Just Got a Regulator

FDA and EMA both moved this week, and the work landed on the CIO's desk.

From Breach to Lawsuit in Days

Amgen and Abbott show the new time compression, and the EU AI Act just raised the stakes again.

AI Governance Just Got Teeth

For the first time, the AI models in your stack have a regulator that can fine, evaluate, and recall them. Here is what landed this week and what it asks of you.

The AI Governance Bar Just Rose — On Both Sides

Regulators are racing to keep up with AI. So are vendors. So is your own org chart. This week's stories all point at the same gap.

Agentic AI Just Crossed Into Your Regulated Workflows

Certara, EDETEK and ProPharma push AI into drug development and submissions — as the first autonomous ransomware hits the same stack.

Your AI Vendor Just Became Your Drug-Discovery Competitor

Anthropic launches Claude Science and its own drug programs; Takeda bets $600M on going AI-native; the EU moves the AI Act goalposts.

Your AI Can't Outrun the Mess You Feed It — 55% of Pilots Prove It

A $2.5B+ deal week rides on clean data. The same week, hackers walked off with 30+ of Novo Nordisk's AI models.

$3 Billion in AI Discovery Deals in One Week — and the Hackers Noticed

BIO 2026 opens with Insilico’s $2.5B CNS pact and Merck’s $510M data flywheel deal. The same week, hackers leaking Novo Nordisk’s stolen AI model data point to a new threat category for pharma CIOs.

Sanofi Goes All-In on Agentic AI — and the Operating Model Gap Just Got Measured

Plus: a third pharma breach in 60 days, MHRA opens an AI sandbox, and only 40% of pharma AI pilots scale.

Five AI Deals in Two Weeks — and FDA Has Already Set the Enforcement Standard

Alnylam's $2B deal, BMS's 30,000-user deployment, and the cGMP precedent your next inspection will test you against

IQVIA's 75% Phase I AI Benchmark Is Now Your Board's Investment Question

Plus: FDA loses three leaders in 72 hours, COINS Act moves toward biotech, and cyber insurers are raising the bar on life sciences terms

A Poisoned VS Code Extension Ran for 18 Minutes. GitHub Lost 3,800 Repositories.

Plus: Pharma AI benchmarks are now board expectations, West Pharma's 16-day recovery sets your BCP reference, and the FDA real-time trials window closes May 29

Life Sciences CIO Weekly Digest – Week of Feb 23–Mar 1, 2026

Life Sciences CIO Weekly Digest – Week of Feb 16–21, 2026